Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4964)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2022 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu YH, Zhu WM, Guo Z. Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease. World J Gastroenterol 2022; 28(48): 6888-6899 [PMID: 36632311 DOI: 10.3748/wjg.v28.i48.6888] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i48/6888.htm |
| Number | Citing Articles |
| 1 |
Małgorzata Godala, Ewelina Gaszyńska, Konrad Walczak, Ewa Małecka-Wojciesko. Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2023; 12(18): 5956 doi: 10.3390/jcm12185956
|
| 2 |
Daopo Lin, Yang Jin, Xiaoxiao Shao, Yuan Xu, Guolong Ma, Yi Jiang, Yinghe Xu, Yongpo Jiang, Dingyuan Hu. Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04711-x
|
| 3 |
Chao Nie, Yunyi Zhao, Pengjie Wang, Ran Wang, Yixuan Li, Xifan Wang, Bing Fang, Xiaoyu Wang, Jing Zhan, Longjiao Zhu, Chong Chen, Weibo Zhang, Haiping Liao, Rong Liu. Momordica charantia Polysaccharide intervention ameliorates the symptoms of dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota and inhibiting inflammation. Journal of Functional Foods 2024; 112: 105970 doi: 10.1016/j.jff.2023.105970
|
| 4 |
J. Ben Shimol. Perimenopause in women with rheumatologic diseases: a spotlight on an under-addressed transition. Climacteric 2024; 27(2): 115 doi: 10.1080/13697137.2023.2276201
|
| 5 |
Tao Xie, Gao-Yao Cao, Shize Zhang, Meng-Ke Li, Xin Jin, Liu Liu, Guangji Wang, Le Zhen. Discovery of Thiazole Carboxamides as Novel Vanin-1 Inhibitors for Inflammatory Bowel Disease Treatment. Journal of Medicinal Chemistry 2024; doi: 10.1021/acs.jmedchem.4c01838
|
| 6 |
Annalisa Di Rienzo, Lisa Marinelli, Marilisa Pia Dimmito, Eleonora Chiara Toto, Antonio Di Stefano, Ivana Cacciatore. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems. Pharmaceutics 2024; 16(9): 1185 doi: 10.3390/pharmaceutics16091185
|
| 7 |
Inmaculada Serrano, Ana Luque, Alexandra Ruiz-Cerulla, Sergio Navas, Anna M. Blom, Santiago Rodríguez de Córdoba, Francisco J. Fernández, M. Cristina Vega, Francisco Rodríguez-Moranta, Jordi Guardiola, Josep M. Aran. C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients. Pharmacological Research 2023; 197: 106948 doi: 10.1016/j.phrs.2023.106948
|
| 8 |
Satyam K. Ghodasara, Kristine M. Hauser, Kaitlyn M. Oldewurtel, Rolando H. Rolandelli, Zoltan H. Nemeth. A Comparison of Clinical Outcomes of Colectomies for Pediatric and Adult Patients With Inflammatory Bowel Disease. The American Surgeon™ 2024; 90(11): 2921 doi: 10.1177/00031348241256066
|
| 9 |
Daniel Schweckendiek, Gerhard Rogler. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?. Digestion 2024; : 1 doi: 10.1159/000540421
|
| 10 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 11 |
Victor O Adedara, Charles A Adedara, Nicola D Ruth, Grant U Alozie, Nate Nettagul. Advancements in the Management of Pediatric and Adult Inflammatory Bowel Disease: A Systematic Review of Treatment Strategies and Long-Term Outcomes. Cureus 2024; doi: 10.7759/cureus.72324
|
| 12 |
Laura Arosa, Miguel Camba-Gómez, Olga Golubnitschaja, Javier Conde-Aranda. Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations. EPMA Journal 2024; 15(1): 111 doi: 10.1007/s13167-024-00351-x
|
| 13 |
Ali Alipouriani, Kamil Erozkan, Lukas Schabl, Himani Sancheti, Shaji Sebastian, Serre-Yu Wong, Phil Tozer, Benjamin L Cohen, Stefan D Holubar. TOpClass Class 4 Perineal Crohn’s Disease: A Systematic Review and Meta-analysis of Perineal Wound Complication After Proctectomy in Crohn’s Patients. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae198
|